UnknownPhase 4

CT-guided Ganglion Impar Block for Management of Phantom Rectal Pain Syndrome

Egypt40 participantsStarted 2018-06-12

Plain-language summary

Background:Patients underwent abdominoperineal resection with colostomy may suffered from phantom rectum pain syndrome in the perineal area.In this study, the investigators evaluate the combination between ganglion impar block to pregabaline in the treatment of phantom rectal pain syndrome. Method: Forty patients were randomly allocated into 2 groups: Group A (n=20) where patients received pregabaline 150 mg twice daily. Group B (n=20) where patients received pregabaline 150 mg twice daily plus ganglion impar block using 5 ml bupivacaine 5% with 14 mg/2 ml betamethasone.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * complained from phantom rectal pain syndrome after abdominoperineal surgery for rectal cancer with colostomy. Exclusion Criteria: * those who refused to share * evidence of local infection at the puncture site * allergy to drugs used * patients with bleeding tendency or coagulopathy, renal or hepatic failure, cardiac patients, * bony abnormality and local malignant recurrence or lower vertebral metastasis.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

numerical rating scale

Timeframe: two months

Participant satisfaction reporting scale (PSRS)

Timeframe: two months

Trial details

NCT IDNCT03694639

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06-01

Contact for this trial

Yahya Mhamed Wahba, MD

01211313554 yahyawahba@ymail.com

View on ClinicalTrials.gov More Pain, Phantom trials